Anzeige
Meldung des Tages: Double Mer Projekt: SAGA zweites strategisches Standbein – Uran für das KI-Zeitalter

Bio-Techne Aktie News

Aktie
WKN:  A12ENG ISIN:  US09073M1045 US-Symbol:  TECH Branche:  Biotechnologie Land:  USA
67,55 $
-2,10 $
-3,02%
57,248 € 20:30:20 Uhr
Depot/Watchlist
Marktkapitalisierung *
7,89 Mrd. €
Streubesitz
-
KGV
109,47
Dividende
0,080 $
Dividendenrendite
0,12%
neu: Nachhaltigkeits-Score
46 %
Index-Zuordnung
S&P 500

Bio-Techne News

06.08.25 - PR Newswire
Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
Bio-​Techne Releases Fourth Quarter Fiscal 2025 Results PR Newswire
06.08.25 - PR Newswire
BIO-TECHNE DECLARES DIVIDEND
BIO-​TECHNE DECLARES DIVIDEND PR Newswire
05.08.25 - PR Newswire
Bio-Techne Announces Exosome Diagnostics Divestiture
Bio-​Techne Announces Exosome Diagnostics Divestiture PR Newswire
05.08.25 - PR Newswire
ScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine
ScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine PR Newswire
31.07.25 - PR Newswire
ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering
ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering PR Newswire
17.07.25 - PR Newswire
Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results
Bio-​Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results PR Newswire
15.07.25 - PR Newswire
Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
Bio-​Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection PR Newswire
14.07.25 - PR Newswire
Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy
Bio-​Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-​Based Gene Therapy PR Newswire
04.07.25 - LYNX Analysen
Bio-Techne: Innovation, Expansion und ein möglicher Kursausbruch
Bio-​Techne könnte vor einem Wachstumsschub stehen. Bisher wird das nicht nur ignoriert, sondern mit einem Kurssturz quittiert. Jetzt vollständige Analyse lesen
24.06.25 - PR Newswire
Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
Bio-​Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development PR Newswire
10.06.25 - PR Newswire
ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics
ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics PR Newswire
29.05.25 - PR Newswire
Bio-Techne to Present at Investor Conferences
Bio-​Techne to Present at Investor Conferences PR Newswire
14.05.25 - PR Newswire
ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA)
ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA) PR Newswire
12.05.25 - PR Newswire
Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025
Bio-​Techne to Showcase Next-​Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025 PR Newswire
08.05.25 - PR Newswire
Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
Kytopen and Bio-​Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing PR Newswire
08.05.25 - PR Newswire
Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
Bio-​Techne to Present at the BofA Securities 2025 Health Care Conference PR Newswire
07.05.25 - PR Newswire
BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
BIO-​TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS PR Newswire
07.05.25 - PR Newswire
BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
BIO-​TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM PR Newswire
06.05.25 - PR Newswire
ScaleReady awards a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc.
ScaleReady awards a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc. PR Newswire
29.04.25 - PR Newswire
ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy
ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy PR Newswire

Newssuche

Videos

newspaper
22.01.26 -5,56%
Trading Insights vom 22.01.26
Preisschock bei Erdgas! Was sind die Gründe, wie geht man damit um? Gold auf neuem Allzeithoch: wie ... Mehr »